As many as 136 million adult Americans may be eligible for Ozempic, researchers estimate. According to a study published Monday in JAMA Network, among the 25,531 participants, 8,504 were eligible for semaglutide. Semaglutide, the active medicine found in the drug, has become a popular option for people looking to lose weight. Ozempic, along with Wegovy,…